A carregar...
Delivery of bevacizumab by intracranial injection: assessment in glioma model
BACKGROUND: Many reports have indicated that the intravenous administration of bevacizumab produces a number of systemic side effects. Therefore, we investigated the therapeutic effects of intratumoral bevacizumab administration using a glioma animal model. METHODS: The glioma cell lines U251 and U8...
Na minha lista:
| Publicado no: | Onco Targets Ther |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5951223/ https://ncbi.nlm.nih.gov/pubmed/29780259 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S159913 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|